SCHEMBL13469455

SCHEMBL13469455

CC[C@@H](O[C@H](CO)C(C)I)n1ccc(N)nc1=O

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 3/20 0.37
PDE3A Q14432 3/20 0.37
PDE4D Q08499 1/20 0.37
SLC29A1 Q99808 1/20 0.37
SLC22A6 Q4U2R8 1/20 0.36
LMNA P02545 3/20 0.34
THRB P10828 1/20 0.34
MTOR P42345 1/20 0.34
MDM2 Q00987 1/20 0.34
NCOA1 Q15788 1/20 0.34
NCOA3 Q9Y6Q9 1/20 0.34
POLA1 P09884 1/20 0.31
CACNA1F O60840 2/20 0.31
ALB P02768 2/20 0.31
MAPT P10636 2/20 0.31
CACNA1D Q01668 2/20 0.31
CACNA1S Q13698 2/20 0.31
CACNA1C Q13936 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17384630 0.83 FGFR1 (0.39) FGFR1PDE3APDE4DSLC29A1SLC22A6
SCHEMBL16513183 0.82 FGFR1 (0.37) FGFR1PDE3APDE4DSLC29A1SLC22A6
SCHEMBL15482195 0.82 FGFR1 (0.37) FGFR1PDE3APDE4DSLC29A1SLC22A6
SCHEMBL22820554 0.81 FGFR1 (0.39) FGFR1PDE3APDE4DSLC29A1SLC22A6
SCHEMBL15576948 0.81 FGFR1 (0.39) FGFR1PDE3APDE4DSLC29A1SLC22A6
SCHEMBL13468606 0.80 FGFR1 (0.37) FGFR1PDE3APDE4DSLC29A1SLC22A6
SCHEMBL24420596 0.79 FGFR1 (0.43) FGFR1PDE3APDE4DSLC29A1SLC22A6
SCHEMBL13468599 0.79 FGFR1 (0.37) FGFR1PDE3APDE4DSLC29A1SLC22A6
SCHEMBL18661627 0.79 FGFR1 (0.37) FGFR1PDE3APDE4DSLC29A1SLC22A6
SCHEMBL13758938 0.79 FGFR1 (0.37) FGFR1PDE3APDE4DSLC29A1SLC22A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012142093-A2 2'-CYANO SUBSTITUTED NUCLEOSIDE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES MERCK SHARP & DOHME CORP. (US) 2012-10-18 WO disclosed